Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 241


Development of a fully automated closed loop artificial pancreas control system with dual pump delivery of insulin and glucagon.

Jacobs PG, El Youssef J, Castle JR, Engle JM, Branigan DL, Johnson P, Massoud R, Kamath A, Ward WK.

Conf Proc IEEE Eng Med Biol Soc. 2011;2011:397-400. doi: 10.1109/IEMBS.2011.6090127.


Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.

Haidar A, Legault L, Dallaire M, Alkhateeb A, Coriati A, Messier V, Cheng P, Millette M, Boulet B, Rabasa-Lhoret R.

CMAJ. 2013 Mar 5;185(4):297-305. doi: 10.1503/cmaj.121265. Epub 2013 Jan 28.


Automated control of an adaptive bihormonal, dual-sensor artificial pancreas and evaluation during inpatient studies.

Jacobs PG, El Youssef J, Castle J, Bakhtiani P, Branigan D, Breen M, Bauer D, Preiser N, Leonard G, Stonex T, Ward WK.

IEEE Trans Biomed Eng. 2014 Oct;61(10):2569-81. doi: 10.1109/TBME.2014.2323248. Epub 2014 May 13.


Computer-aided continuous drug infusion: setup and test of a mobile closed-loop system for the continuous automated infusion of insulin.

Dudde R, Vering T, Piechotta G, Hintsche R.

IEEE Trans Inf Technol Biomed. 2006 Apr;10(2):395-402.


Artificial pancreas: an emerging approach to treat Type 1 diabetes.

Kumareswaran K, Evans ML, Hovorka R.

Expert Rev Med Devices. 2009 Jul;6(4):401-10. doi: 10.1586/erd.09.23. Review.


Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies.

Wilinska ME, Budiman ES, Taub MB, Elleri D, Allen JM, Acerini CL, Dunger DB, Hovorka R.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1109-20.


Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.

Weinzimer SA, Steil GM, Swan KL, Dziura J, Kurtz N, Tamborlane WV.

Diabetes Care. 2008 May;31(5):934-9. doi: 10.2337/dc07-1967. Epub 2008 Feb 5.


Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience.

Clarke WL, Anderson S, Breton M, Patek S, Kashmer L, Kovatchev B.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1031-8.


Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier.

Bruttomesso D, Farret A, Costa S, Marescotti MC, Vettore M, Avogaro A, Tiengo A, Dalla Man C, Place J, Facchinetti A, Guerra S, Magni L, De Nicolao G, Cobelli C, Renard E, Maran A.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1014-21.


Safety auxiliary feedback element for the artificial pancreas in type 1 diabetes.

Revert A, Garelli F, Pico J, De Battista H, Rossetti P, Vehi J, Bondia J.

IEEE Trans Biomed Eng. 2013 Aug;60(8):2113-22. doi: 10.1109/TBME.2013.2247602. Epub 2013 Feb 15.


Artificial beta-cell: clinical experience toward an implantable closed-loop insulin delivery system.

Renard E, Costalat G, Chevassus H, Bringer J.

Diabetes Metab. 2006 Dec;32(5 Pt 2):497-502. Review.


[Closed-Loop at night for the treatment of type 1 diabetes].

Danne T, Kordonouri O.

Dtsch Med Wochenschr. 2014 Oct;139(42):2156. doi: 10.1055/s-0034-1387318. Epub 2014 Oct 7. Review. German.


A bio-inspired glucose controller based on pancreatic β-cell physiology.

Herrero P, Georgiou P, Oliver N, Johnston DG, Toumazou C.

J Diabetes Sci Technol. 2012 May 1;6(3):606-16.


A closed-loop artificial pancreas using model predictive control and a sliding meal size estimator.

Lee H, Buckingham BA, Wilson DM, Bequette BW.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1082-90.


Insulin patch pumps: their development and future in closed-loop systems.

Anhalt H, Bohannon NJ.

Diabetes Technol Ther. 2010 Jun;12 Suppl 1:S51-8. doi: 10.1089/dia.2010.0016.


Glucose clamp algorithms and insulin time-action profiles.

Bequette BW.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1005-13. Review.


Factors affecting the success of glucagon delivered during an automated closed-loop system in type 1 diabetes.

Bakhtiani PA, El Youssef J, Duell AK, Branigan DL, Jacobs PG, Lasarev MR, Castle JR, Ward WK.

J Diabetes Complications. 2015 Jan-Feb;29(1):93-8. doi: 10.1016/j.jdiacomp.2014.09.001. Epub 2014 Sep 16.


Control to range for diabetes: functionality and modular architecture.

Kovatchev B, Patek S, Dassau E, Doyle FJ 3rd, Magni L, De Nicolao G, Cobelli C; Juvenile Diabetes Research Foundation Artificial Pancreas Consortium.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1058-65.


A review of artificial pancreas technologies with an emphasis on bi-hormonal therapy.

Bakhtiani PA, Zhao LM, El Youssef J, Castle JR, Ward WK.

Diabetes Obes Metab. 2013 Dec;15(12):1065-70. doi: 10.1111/dom.12107. Epub 2013 Apr 21. Review.

Items per page

Supplemental Content

Write to the Help Desk